Approaches to Pharmaceutical Analysis of an Innovative Liposomal Preparation for Treating Hepatitis C
- Autores: Smirnov V.V.1,2,3, Krasnykh L.M.1, Shilovskii I.P.2, Ryzhenkova A.P.3, Khaitov M.R.2, Drozdov V.N.3
- 
							Afiliações: 
							- Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
- Institute of Immunology, Federal Medico-Biological Agency of the Russian Federation
- I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
 
- Edição: Volume 52, Nº 3 (2018)
- Páginas: 254-256
- Seção: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245109
- DOI: https://doi.org/10.1007/s11094-018-1802-9
- ID: 245109
Citar
Resumo
The composite Y14/siUTR, a complex consisting of cationic lipopeptide Y14 as an excipient and pharmaceutical substance of small interfering RNAtargeted against the UTR region of hepatitis C virus (siUTR), was investigated. The composite was intended to inhibit the hepatitis C virus replication cycle. The present work was aimed at developing pharmaceutical analytical methods for the components of this composite using HPLC-UV and UV spectroscopy.
Palavras-chave
Sobre autores
V. Smirnov
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation; Institute of Immunology, Federal Medico-Biological Agency of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
														Email: chem@folium.ru
				                					                																			                												                	Rússia, 							8/2 Petrovskii Blvd., Moscow, 127051; Moscow, 115478; Moscow, 119991						
L. Krasnykh
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
														Email: chem@folium.ru
				                					                																			                												                	Rússia, 							8/2 Petrovskii Blvd., Moscow, 127051						
I. Shilovskii
Institute of Immunology, Federal Medico-Biological Agency of the Russian Federation
														Email: chem@folium.ru
				                					                																			                												                	Rússia, 							Moscow, 115478						
A. Ryzhenkova
I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
														Email: chem@folium.ru
				                					                																			                												                	Rússia, 							Moscow, 119991						
M. Khaitov
Institute of Immunology, Federal Medico-Biological Agency of the Russian Federation
														Email: chem@folium.ru
				                					                																			                												                	Rússia, 							Moscow, 115478						
V. Drozdov
I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
														Email: chem@folium.ru
				                					                																			                												                	Rússia, 							Moscow, 119991						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					